93 related articles for article (PubMed ID: 5592993)
1. [On the effect of a new adjuvant on the clinical course of cancer disease in man. II. Observations on the effect of an adjuvant medication in surgically incurable cancer cases].
Moser H
Krebsarzt; 1967; 22(4):219-21. PubMed ID: 5592993
[No Abstract] [Full Text] [Related]
2. [On the effect of a new adjuvant on the clinical course of cancer disease in man. 3. Report of an observation in the cytostatic treatment of inoperable bronchial carcinoma].
Zahlbruckner E
Krebsarzt; 1967; 22(4):221-3. PubMed ID: 5592994
[No Abstract] [Full Text] [Related]
3. [On the effect of a new adjuvant on the clinical course of cancer disease in man. I. Synthesis, chemical constitution and pharmacology].
Pongratz A
Krebsarzt; 1967; 22(4):217-9. PubMed ID: 5592992
[No Abstract] [Full Text] [Related]
4. [Clinical evaluation of anticancer therapy combined with p-aminobenzoic acid-N-xyloside].
Fujimoto S; Ishigami H; Okui K
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1574-9. PubMed ID: 6985199
[TBL] [Abstract][Full Text] [Related]
5. [Clinical trial of K-247].
Kanamaru R; Takahashi K; Mitachi Y; Kanbe M; Sato T; Kakuta H; Wakui A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2122-7. PubMed ID: 6985188
[TBL] [Abstract][Full Text] [Related]
6. [60 cases of advanced cancer treated by an association of ambulatory cytostatics during 1 to 4 years. Collaborational hospital consultation and doctors in charge of the cases].
Israel L; Depierre A
Therapeutique; 1970 Apr; 46(4):415-7. PubMed ID: 4987709
[No Abstract] [Full Text] [Related]
7. Testosterone enanthate as an adjuvant in the management of advanced cancer patients.
Lahiri SR; Boileau G; Piro AJ; Biano G; Nevinny HB; Hall TC
J Med; 1971; 2(1):1-12. PubMed ID: 5285420
[No Abstract] [Full Text] [Related]
8. [Antitumor effects of p-aminobenzoic acid-N-xyloside Na--effects of single administration and combination with radiotherapy].
Fukushima M; Ota K
Gan To Kagaku Ryoho; 1982 Feb; 9(2):230-7. PubMed ID: 6985191
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of oral anticancer agents for colorectal cancer.
Sakamoto J; Oba K; Matsui T; Kobayashi M
Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S82-91. PubMed ID: 17106820
[No Abstract] [Full Text] [Related]
10. A murine plasmacytoma model for screening active drugs for human myeloma.
Hiramoto RN; Ghanta VK; Durant JR; Hiramoto NS
Cancer Clin Trials; 1980; 3(4):395-402. PubMed ID: 7428144
[TBL] [Abstract][Full Text] [Related]
11. Clinical correlations of in vitro drug sensitivity.
Salmon SE; Alberts DS; Meyskens FL; Durie BG; Jones SE; Soehnlen B; Young L; Chen HS; Moon TE
Prog Clin Biol Res; 1980; 48():223-45. PubMed ID: 7193872
[No Abstract] [Full Text] [Related]
12. Insulin, chemotherapy, and the mechanisms of malignancy: the design and the demise of cancer.
Ayre SG; Garcia y Bellon DP; Garcia DP
Med Hypotheses; 2000 Oct; 55(4):330-4. PubMed ID: 11000062
[TBL] [Abstract][Full Text] [Related]
13. The clinical application of drug dosing schedules in cancer therapy--Part II.
Reich SD
Cancer Nurs; 1984 Feb; 7(1):59-61. PubMed ID: 6559098
[No Abstract] [Full Text] [Related]
14. Side effects and good effects from new chemotherapeutic agents. Case 3. Bortezomib in primary refractory plasmacytoma.
Chim CS; Ooi GC; Loong F; Au AW; Lie AK
J Clin Oncol; 2005 Apr; 23(10):2426-8. PubMed ID: 15800336
[No Abstract] [Full Text] [Related]
15. [Indication for neoplasm chemotherapy and administration of antineoplastic agents].
Hiraki K; Kimura I
Naika; 1970 Jun; 25(6):1163-9. PubMed ID: 5431259
[No Abstract] [Full Text] [Related]
16. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
17. [Principles for adjuvant and neoadjuvant chemotherapy].
Fukuoka M; Tsuchiya R
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():333-7. PubMed ID: 7986112
[TBL] [Abstract][Full Text] [Related]
18. [218 cases of prolonged polychemotherapy in advanced cancer (especially bronchopulmonary). Modalities and results].
Israel L; Bernard E
Poumon Coeur; 1968; 24(1):63-8. PubMed ID: 5690023
[No Abstract] [Full Text] [Related]
19. Intraperitoneal chemotherapy in the management of malignant disease.
Markman M
Expert Rev Anticancer Ther; 2001 Jun; 1(1):142-8. PubMed ID: 12113122
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
